Randomized, double-blind, placebo-controlled, multicenter study of siltuximab in high-risk smoldering multiple myeloma
by Brighton, Timothy (Author)
, Khot, Amit (Author)
, Harrison, Simon J. (Author)
, Ghez, David (Author)
, Weiss, Brendan M. (Author)
, Kirsch, Andreas (Author)
, Magen, Hila (Author)
, Gironella, Mercedes (Author)
, Oriol, Albert (Author)
, Streetly, Matthew (Author)
, Kranenburg, Britte (Author)
, Qin, Xiang (Author)
, Bandekhar, Rajesh (Author)
, Hu, Peter (Author)
, Guilfoyle, Mary (Author)
, Qi, Ming (Author)
, Nemat, Sepideh (Author)
, Goldschmidt, Hartmut (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource